BrigatinibBrigatinib
Common
Rarity: Common
The most frequent rarity: most Wikipedia articles become Commons.
Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.
At a glance
- Class
- Notion
- Domain
- Science and technology
- In collections
- Nobody has pulled it yet.
What Wikipedia says
Brigatinib, sold under the brand name Alunbrig among others, is a small-molecule targeted cancer therapy being developed by Ariad Pharmaceuticals, Inc. Brigatinib acts as an inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR), as well as several nonreceptor tyrosine kinases such as FAK, FAK2, and FER.
Excerpt from the Wikipedia article “Brigatinib”, under the CC BY-SA 4.0 license. Read the article on Wikipedia
Image: Ed (Edgar181), Public domain, via Wikimedia Commons.
Open free boosters and add Brigatinib to your collection.
Play for free

